Johnston V - Search Results

1

High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experience.

Kong G, Johnston V, Ramdave S, Lau E, Rischin D, Hicks RJ. Kong G, et al. Among authors: johnston v. Cancer Biother Radiopharm. 2009 Oct;24(5):527-33. doi: 10.1089/cbr.2009.0644. Cancer Biother Radiopharm. 2009. PMID: 19877882

2

68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA.

Hofman M, Binns D, Johnston V, Siva S, Thompson M, Eu P, Collins M, Hicks RJ. Hofman M, et al. Among authors: johnston v. J Nucl Med. 2015 Mar;56(3):405-9. doi: 10.2967/jnumed.114.147843. Epub 2015 Feb 12. J Nucl Med. 2015. PMID: 25678493 Free article. Clinical Trial.

3

Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy.

Lau WF, Zacharin MR, Waters K, Wheeler G, Johnston V, Hicks RJ. Lau WF, et al. Among authors: johnston v. Intern Med J. 2006 Sep;36(9):564-70. doi: 10.1111/j.1445-5994.2006.01149.x. Intern Med J. 2006. PMID: 16911548

4

Intraperitoneal distribution imaging in ovarian cancer patients.

Dawson SJ, Hicks RJ, Johnston V, Allen D, Jobling T, Quinn M, Rischin D. Dawson SJ, et al. Among authors: johnston v. Intern Med J. 2011 Feb;41(2):167-71. doi: 10.1111/j.1445-5994.2009.02112.x. Intern Med J. 2011. PMID: 19849742 Clinical Trial.

5

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).

Kong G, Thompson M, Collins M, Herschtal A, Hofman MS, Johnston V, Eu P, Michael M, Hicks RJ. Kong G, et al. Among authors: johnston v. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1831-44. doi: 10.1007/s00259-014-2788-5. Epub 2014 May 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24844348 Free PMC article.

6

Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.

Millward MJ, Webster LK, Toner GC, Bishop JF, Rischin D, Stokes KH, Johnston VK, Hicks R. Millward MJ, et al. Among authors: johnston vk. Aust N Z J Med. 1996 Jun;26(3):372-9. doi: 10.1111/j.1445-5994.1996.tb01925.x. Aust N Z J Med. 1996. PMID: 8811211

7

Occupational Exposure in Nuclear Medicine and PET.

White S, Binns D, Johnston V V, Fawcett M, Greer B, Ciavarella F, Hicks R. White S, et al. Among authors: johnston v v. Clin Positron Imaging. 2000 May;3(3):127-129. doi: 10.1016/s1095-0397(00)00044-3. Clin Positron Imaging. 2000. PMID: 11008102

8

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6. Lancet. 2022. PMID: 35908569 Free PMC article.

9

Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.

Sheel M, Vun Voo T, Pingault N, Sloan-Gardner TS, Marmor A, Kirk MD, Johnston V, Coleman K. Sheel M, et al. Among authors: johnston v. Commun Dis Intell (2018). 2022 Jun 23;46. doi: 10.33321/cdi.2022.46.32. Commun Dis Intell (2018). 2022. PMID: 35739073 Free article.

10

Exploring the perspectives of key stakeholders in returning to work after minor to serious road traffic injuries: a qualitative study.

Abedi M, Aplin T, Gane E, Johnston V. Abedi M, et al. Among authors: johnston v. J Occup Rehabil. 2022 Jun 20. doi: 10.1007/s10926-022-10051-w. Online ahead of print. J Occup Rehabil. 2022. PMID: 35723805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results